Science Explorer Back to mapMap
Discussion
Researcher · The University of Texas Health Science Center at Houston · United States

Neeraja Dharmaraj

Neeraja Dharmaraj publishes mostly in Immunology, Molecular Biology and Oncology, on topics such as Glycosylation and Glycoproteins Research, Cancer Immunotherapy and Biomarkers and Immunotherapy and Immune Responses.

OpenAlex
World rank
#1,719,427
of 7,710,434 ranked researchers
Rank in United States
#531,084
of 1,627,098
Works
41
Citations
765
Citations per work
18.7
h-index
15
i10-index 16Top 48% in Immunology
Neeraja Dharmaraj

What does Neeraja Dharmaraj research?

Neeraja Dharmaraj's work is mostly in Biochemistry, Genetics and Molecular Biology (22%), Medicine (22%), Immunology and Microbiology (19%).

Life Sciences: 17 works · 40.5% of their workBiochemistry, Genetics and Molecular Biology: 9 works · 21.5% of their workMolecular Biology: 7 works · 16.5% of their workCancer Research: 2 works · 5.0% of their workImmunology and Microbiology: 8 works · 19.0% of their workImmunology: 8 works · 19.0% of their workEverything else: 14 works · 33.9% of their workHealth Sciences: 9 works · 21.5% of their workMedicine: 9 works · 21.5% of their workOncology: 6 works · 15.7% of their workRadiology, Nuclear Medicine and Imaging: 2 works · 5.8% of their workPhysical Sciences: 2 works · 4.1% of their workEngineering: 2 works · 4.1% of their workBiomedical Engineering: 2 works · 4.1% of their workTHEIR WORKNeeraja Dharmaraj41works
Life Sciences40%Physical Sciences4%Health Sciences22%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology921.5%
    2. Immunology and Microbiology819.0%
  2. Everything else1433.9%
    1. Medicine921.5%
    1. Engineering24.1%
  1. 1Immunology19% of their works
  2. 2Molecular Biology16% of their works
  3. 3Oncology16% of their works
  4. 4Radiology, Nuclear Medicine and Imaging6% of their works
  5. 5Cancer Research5% of their works
  6. 6Biomedical Engineering4% of their works

Research topics

Which keywords describe Neeraja Dharmaraj's research?

The keywords of their largest research topics: Cancer, Glycosylation, Tumor Microenvironment, Immunity, Glycans, Immune System, Immune Checkpoint Blockade and PD-1 and PD-L1.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Cancer132 topics
  2. Glycosylation132 topics
  3. Tumor Microenvironment112 topics
  4. Immunity102 topics
  5. Glycans81 topic
  6. Immune System81 topic
  7. Immune Checkpoint Blockade71 topic
  8. PD-1 and PD-L171 topic
  9. Activation51 topic
  10. Cancer Immunotherapy51 topic
  11. Decidual NK Cells51 topic
  12. Dendritic Cells51 topic
  13. Fc Receptors51 topic
  14. Macrophage51 topic
  15. Regulatory T Cells51 topic
  16. Therapeutic Antibodies51 topic
  17. HIF-141 topic
  18. RNA Interference41 topic
  19. Warburg Effect41 topic
  20. siRNA Delivery41 topic

Where does Neeraja Dharmaraj work?

Neeraja Dharmaraj's main affiliation in the publication record is The University of Texas Health Science Center at Houston, United States.

How many publications and citations does Neeraja Dharmaraj have?

OpenAlex counts 41 works and 765 citations for Neeraja Dharmaraj, an h-index of 15, ranking #1,719,427 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Neeraja Dharmaraj. Posts are plain text and can be reported.